Hypertension-type obese gene individualization intervention composition and preparation method and system
A technology of obesity genes and compositions, applied in biochemical equipment and methods, bioreactor/fermenter combination, biochemical instruments, etc., can solve the problems of limited theoretical basis, lack of practical applicable execution technology, etc., and achieve easy operation Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0112] The collection of embodiment 1 individual sample DNA
[0113] The DNA sample collection that present embodiment adopts is saliva sample, and specific implementation method is:
[0114] ① Tear off the outer packaging of the sampling swab, and take out the sampling swab.
[0115] ②The sampling swab was scraped up and down the left cheek in the mouth for more than 40 times.
[0116] ③Push the push rod of the sampling swab, and send the sampling swab head with the oral epithelial cells scraped into the sampling tube.
[0117] ④Repeat the above operation, take a sample from the right cheek of the mouth, and send the cotton head into another sampling tube.
[0118] The sample DNA taken is collected and numbered, and the next step of genetic testing is carried out after the sample file is established.
Embodiment 2
[0119] Example 2 Establishment of Joint Genotype Risk Level 1
[0120] The polymorphic sites detected in this example are: rs5051 (AGT), rs5186 (AGTR1) and rs1799983 (NOS3), which are marked as a, b, and c respectively, and their subtype risks are shown in Table 8 below :
[0121] Table 8
[0122] genetic polymorphism site
[0123] The risk grades calculated according to the single gene risk listed in Table 8 are shown in Table 4 above.
Embodiment 3
[0124] Example 3 Establishment of Joint Genotype Risk Level II
[0125] The polymorphic sites detected in this example are: rs5051 (AGT), rs5186 (AGTR1), rs1799983 (NOS3) and rs5443 (GNB3), which are respectively marked as a, b, c, d, and their subtypes The degree of risk is shown in Table 9 below:
[0126] Table 9
[0127] genetic polymorphism site
genotype
Risk (OR)
a
1(AA)
0.56
2(AG)
0.56
3(GG)
3.78
b
1(AA)
0.37
13 -->
2(AC)
2.71
3(CC)
2.71
c
1(GG)
0.21
2(GT)
4.21
3(TT)
4.21
d
1(CC)
0.45
2(CT)
2.2
3(TT)
2.2
[0128] The risk level calculated based on the single gene risk listed in the above table is shown in Table 10 below:
[0129] Table 10
[0130]
[0131]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com